Can10
Healthy, Plaque Psoriasis
Phase I
Recruiting
A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.
Nov 16, 2023
―
Carboplatin, Gemcitabine, Nadunolimab
Triple Negative Breast Cancer
Phase I/II
Active Not Recruiting
Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer.
Dec 01, 2021
―
Can04 (Nadunolimab), Mfolfox, Dtx, G/C
Colorectal Cancer, Biliary Tract Cancer, Non Small Cell Lung Cancer, Advanced Solid Tumors
Phase I/II
Completed
A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors
Oct 07, 2021
―
Can04, Folfirinox
Metastatic Pancreatic Ductal Adenocarcinoma
Phase I
Completed
A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
Jun 21, 2021
―
Carboplatin, Pembrolizumab, Pemetrexed, Can04
Carcinoma, Non-small-cell Lung, Head And Neck Squamous Cell Carcinoma, Malignant Melanoma, Urothelial Carcinoma
Phase I
Completed
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors
Jun 24, 2020
―
Carboplatin, Gemcitabine, Cisplatin, Nab-paclitaxel, Pemetrexed, Can04
Colorectal Cancer, Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma
Phase I/II
Completed
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
Aug 24, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cantargia AB (7V3) have in its pipeline
7V3 is currently developing the following drugs: Can10, Carboplatin, Gemcitabine, Nadunolimab, Can04 (Nadunolimab), Mfolfox, Dtx, G/C. These drug candidates are in various stages of clinical development as the company works toward FDA approval.